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Abstract
Background: Cystic Fibrosis (CF) lung disease is characterized by liquid hyperabsorption, airway surface dehydration, and
impaired mucociliary clearance (MCC). Herein, we present a compartment-based mathematical model of the airway that
extends the resolution of functional imaging data.
Methods: Using functional imaging data to inform our model, we developed a system of mechanism-motivated ordinary
differential equations to describe the mucociliary clearance and absorption of aerosolized radiolabeled particle and small
molecules probes from human subjects with and without CF. We also utilized a novel imaging metric in vitro to gauge the
fraction of airway epithelial cells that have functional ciliary activity.
Results: This model, and its incorporated kinetic rate parameters, captures the MCC and liquid dynamics of the
hyperabsorptive state in CF airways and the mitigation of that state by hypertonic saline treatment.
Conclusions: We postulate, based on the model structure and its ability to capture clinical patient data, that patients with
CF have regions of airway with diminished MCC function that can be recruited with hypertonic saline treatment. In so doing,
this model structure not only makes a case for durable osmotic agents used in lung-region specific treatments, but also may
provide a possible clinical endpoint, the fraction of functional ciliated airway.
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Introduction
Cystic Fibrosis (CF) is an autosomal recessive disease that arises
from a defect in the Cystic Fibrosis Transmembrane Conductance
Regulator (CFTR) gene. CF affects multiple organ systems, with
the most detrimental effects occurring in the lungs [1]. CFTR
encodes an anion channel on epithelial surfaces, that is dysfunc-
tional or absent from the CF epithelium. The associated loss of
Cl{ and HCO{3 secretion along with a tendency to hyperabsorb
Naz through the epithelial sodium channel (ENaC) results in
osmotic gradients that favor rapid absorption of the airway surface
liquid (ASL) layer, leading to dehydrated airway mucus secretions
and impaired mucociliary clearance (MCC) [2], [3]. The inability
to clear pathogens via MCC leads to chronic infection, inflam-
mation, airway damage, and premature respiratory failure.
Inhaled agents that reverse osmotic gradients in the airways are
used to treat the ASL dehydration defect associated with CF.
Hypertonic saline (HS) is one such osmotic agent that has been
shown to increase both MCC and lung function in patients with
CF [4], [5]. More recently CFTR modulators have been
developed that substantially improve lung function in individuals
with specific CFTR mutations [6].
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Outcome measures and biomarkers that quantify the basic
pathophysiology of CF lung disease are needed to allow for the
rapid screening of new therapeutics for CF. Ideally, these
screening methods seek to quantify the basic pathophysiology of
CF lung disease. Mucociliary clearance scans, which quantify the
clearance of a radiolabeled particulate from the lungs, are one
such functional imaging method for studying outcomes in CF. We
have expanded this method to include measuring the clearance of
a radiolabeled small-molecule that can be absorbed as well as
cleared via MCC. Similar techniques have been used in the past to
resolve the individual components of lung clearance [7], [8]. Our
in vivo method utilizes Technetium 99m sulfur colloid (Tc-SC) as
the non-absorbable particle probe and Indium 111-DTPA
(DTPA) as the small molecule probe. The probes are delivered
together in a liquid aerosol. Figure 1 presents a schematic for
pharmaceutical clearance from the airway epithelium. We assume
that MCC clears the probes at similar rates and that the difference
in their clearance rates is therefore associated with the absorption
of the small molecule. Previous in vitro studies have demonstrated
a relationship between DTPA and airway surface liquid absorp-
tion rates [9]. DTPA absorption is increased both in vivo in CF
airways and in vitro in CF airway cell cultures [9], [10]. Decreases
in DTPA absorption after osmotic therapies have also been
demonstrated in vitro and in vivo [9], [10]. Thus, multi-probe
methods provide measurements of both MCC and ASL absorp-
tion rates [10]. Successful CF therapies should restore ASL volume
by correcting defective airway epithelial ion transport [11], [12].
The restoration of airway hydration should be rapidly detectable
through these multi-probe imaging methods as decreased liquid
absorption rates are reflected through slower absorption of DTPA
and improvements in MCC cause increased Tc-SC clearance.
Herein we present a compartment-based model of particle and
small molecule clearance from the human respiratory tract that
uses functional imaging data to inform model structure and
quantitate parameter values. Our goal in developing this model is
to better resolve the specific physiological mechanisms that
contribute to the composite functional imaging result. We believe
that these mechanism-specific measurements may provide more
sensitive and specific evaluations of therapeutic efficacy than the
currently used image-derived metrics. The challenge is to
construct a mathematical representation of the physiology that
can resolve the underlying mechanisms and their interactions.
There have been a number of compartment-based pharmaco-
kinetic (PK) models for inhaled pharmaceuticals [13], [14], [15],
[16], [17], but to our knowledge none have considered the PK
behavior of the radiopharmaceuticals used for functional imaging
from which our data originates, nor has anyone assessed
absorption kinetics with the methodology we have employed.
We hypothesize that by dividing the lung into a solely absorptive
peripheral lung region and separate central lung region that has
both absorptive and MCC capability, and by subdividing this
central lung region into fractions with, and without, functional
ciliated airway, we can reproduce the dynamics of simultaneous
particle and small molecule probe clearance from the lung. We
further hypothesize that (i) functional ciliated airway clears at the
same rate in patients with CF and non-CF subjects; (ii) the fraction
of functional ciliated airway (FFCA) is decreased in CF; and (iii)
FFCA can be increased through inhalation of HS. Our models
provide estimates of FFCA, MCC, and large airway and
peripheral lung absorption, the latter of which we believe is
related to liquid hyper-absorption in CF small airways. These
measured parameters may substantially expand the utility of our
functional imaging measurement by providing more mechanistic
insight into lung physiology and response to therapeutic agents (a
list of all abbreviations and their definition used in this work can be
found in Table 1).
Results
Model Synthesis and Assumptions
Starting from the original model of Sakagami [15], we extend it
structurally to account for the dynamics and kinetics observed in
Figure 1. Left panel: schematic of transport routes in the airway epithelium. The black and white horizontal arrows represent mucociliary
clearance of Tc-SC and DTPA, respectively. DTPA (downward white arrow) absorbs across the airway epithelium via the paracellular route. Water
(downward blue arrow) also absorbs across the epithelium via the transcellular and paracellular route. Right panel: normalized Tc-SC (blue circles) and
DTPA (green circles) retention curves with the difference between the respective datasets at each time point shown as absorption (red circles) in CF
subject 8.
doi:10.1371/journal.pone.0111972.g001
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the clinical data set. Founded on a basic understanding of lung
anatomy and physiology, the lung structure can be lumped into
two key dynamical structures as shown in Figure 2. Additional
assumptions made in synthesizing this model are as follows:
N A fraction of the large airways (L), which are represented in
the central (C) lung region of interest (ROI) [18], has
functional MCC, with MCC in the remainder of L being
non-functional. This allows the subdivision of L into two sub-
compartments: LF , which has functional MCC, and LN ,
which has no functional MCC.
N The initial doses of the radiopharmaceuticals delivered to
either the central (C0) or peripheral (P0) lung regions are
described as the number of counts within C or in the area
outside of C but within the whole lung ROI in the first image,
respectively [10] (Figure S1 provides a visual representation of
the C and P ROIs).
N 10% of inhaled radiopharmaceuticals were assumed to deposit
in the trachea (T0) [15]. However, neither counts in T nor the
bloodstream (B) have a unique impact on the clearance of the
Tc-SC and DTPA.
N MCC in the distal lung D, which contains small and
intermediate-sized airways in addition to alveoli [18], is a
slow process; given the 80-min timescale of our data this rate
cannot be resolved with confidence. As a result, the MCC term
from D to L, kDL, is neglected.
The result of these assumptions is a three-compartment model
for MCC in the lung wherein two compartments (D and LN ) are
absorptive and one compartment (LF ) has MCC in addition to
absorptive clearance, as shown in Figure 2.
Model Equations
Equations modeling the transport of both of the probes are
outlined below. The model parameters kLT , kDB, kLB and FFCA,
the fraction of L with functional MCC, were determined by
nonlinear least-squares regression as described in Methods. For
Tc-SC clearance, kDB and kLB are set equal to 0. The
mathematical description of this model, written as ODEs
representing the change in counts in each model compartment,
is as follows (see Table 2 for full list of model abbreviations):
dD
dt
~{kDBD ð1Þ
dLN
dt
~{kLBLN ð2Þ
dLF
dt
~{kLBLF{kLTLF ð3Þ
dT
dt
~kLTLF ð4Þ
Table 1. Abbreviations and constants in the work presented herein.
Abbreviation Description
AIC Akaike Information Criterion; a Metric of Model Appropriateness
ASL Airway Surface Liquid Layer
C Imaging Region of Interest About the Central Lung; Analogous to L in Model
CF Cystic Fibrosis
CFTR Cystic Fibrosis Transmembrane Conductance Regulator
CI Confidence Interval
DMEM Dulbecco’s Modified Eagle Medium
DTPA Indium-111 Diethylene Triamine Pentaacetic Acid
ENaC Epithelial Sodium Channel
FFCA Fraction of Functional Ciliated Airway
HBE Human Bronchial Epithelial (cell)
HS Hypertonic Saline
IS Isotonic Saline
k Number of Free Parameters in Model
MCC Mucociliary Clearance
N Number of Data Points Analyzed for Model Fit
ODE Ordinary Differential Equation
PK Pharmacokinetic
Tc-SC Technetium-99m Sulfur Colloid
Wi Weighting Factor of the ith Element of the Dataset for AIC
yi ith Value of Dataset
y^i ith Value of Model Fit
doi:10.1371/journal.pone.0111972.t001
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dB
dt
~kDBDzkLB(LNzLF ) ð5Þ
Model Fit and Predictions
The ability of our model to reproduce therapeutic response after
the inhalation of hypertonic saline was studied using imaging data
from patients with CF who inhaled isotonic saline (IS) and
hypertonic saline on alternating study days [10]. Retention of Tc-
SC, which is a metric of MCC, is shown with model fit for each
patient group in Figure 3 [3]. Data from pediatric patients with
CF and healthy controls who inhaled isotonic saline is also shown.
The model captured the dynamics of MCC in all patient groups.
The previously described increases in MCC associated with HS
inhalation are apparent in the image-derived data and the model
fits. However, as previously reported, no statistical differences in
baseline MCC were detected between the CF IS, pediatric CF,
and control groups [10].
DTPA is assumed to deposit in the same regions and clear by
MCC at the same rate as Tc-SC; DTPA absorption is then
captured by regressing the parameters kDB and kLB. Additionally,
our previous studies have shown that the absorption of DTPA
indicates changes in the absorption of ASL [9]. As such, the effect
of hypertonic saline on liquid absorption, using DTPA as an
analog, is shown in Figure 4, along with the model fit for each
group [10]. The model again captured the dynamics of absorption
in all groups. Increased baseline rates of DTPA absorption are
apparent in both adult and pediatric CF groups, as previously
described [10].
Our model predicts that both Tc-SC retention and liquid
absorption will follow trajectories within narrow envelopes based
on the predicted upper and lower 95% confidence intervals (CIs)
of the model parameters. These CI envelopes are derived using all
possible combinations of the upper and lower 95% CIs and
nominal values of the model parameters to generate the extreme
values of model predictions. Figure 5 shows that predicted model
trajectories lead to different final values of Tc-SC retention for all
adult patient groups, with no overlap in trajectory envelopes of CF
IS and non-CF groups for t.18 min and no overlap between non-
CF and HS trajectories for t.27 min. In other words, the three
adult patient subgroups have characteristically different total
MCC behavior. Pediatric CF clearance trajectories closely
resemble those of adult patients with CF, but are not shown for
ease of interpretation. Patients with CF display less MCC than
non-CF subjects, which appears to contradict our finding in [10].
However, the present work evaluates the entire time course of
clearance, while the end of study value (t = 80 min) was used as the
evaluation time point in [10]. By using the entire data sequence,
particularly the dynamic response at short times, we are able to
parametrically estimate and differentiate - with confidence - the
MCC and absorption dynamics between patients with CF and
Figure 2. Schematic model structure describing the clearance of small molecule and particle probes from the lung. Initial depositions:
T0 = trachea, C0 = central, P0 =peripheral. See Table 1 for full list of model abbreviations.
doi:10.1371/journal.pone.0111972.g002
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non-CF subjects. These analyses also indicate that MCC function
in patients with CF can be rescued by HS treatment, which caused
total MCC to exceed that of non-CF subjects.
Figure 6 shows that the model-predicted trajectories for liquid
absorption have no overlap for all t.0. Pediatric CF trajectories
again resemble those of adult patients with CF, but are not shown.
Patients with CF have higher absorption than non-CF subjects,
which can be partially remediated by HS treatment. Combined,
the results in Figures 5 and 6 indicate that HS has two distinct
mechanisms of action, both rescuing MCC and ameliorating
liquid hyperabsorption [4].
It has been proposed that the apparent increase of MCC
following HS treatment occurs by increasing the rate at which
MCC occurs [4], [19]. Our model suggests that the intrinsic rate
of MCC is the same in all patient groups, and the rescue of MCC
can be attributed to the recruitment of inactive portions of the
airway. Figure 7A shows that the rate of MCC, kLT , is not
significantly different between all patient groups (p.0.05).
Table 2. Model parameters in the work presented herein.
Parameter Description
B Bloodstream Model Compartment (units counts)
C0 Initial Counts in L (units counts)
D Distal Lung Model Compartment (units counts)
FFCA Free Parameter; Fraction of C0 in LF (units counts)
L Large Airway Model Super-Compartment (units counts)
LF Sub-compartment of L with Functional MCC (units counts)
LN Sub-compartment of L without Functional MCC (units counts)
kDB Free Parameter; Rate Constant of Absorption in D (units min{1)
kDL Free Parameter (Unused in Final Model); Rate Constant of MCC from D to L
(units min{1)
kLB Free Parameter; Rate Constant of Absorption in L (units min{1)
kLT Free Parameter; Rate Constant of MCC from L to T (units min{1)
P0 Initial Counts in D (units counts)
T Trachea Model Compartment (units counts)
doi:10.1371/journal.pone.0111972.t002
Figure 3. Tc-SC retention (mean+SEM) vs. model fit (black line) for four patient subgroups. (A) Non-CF subjects (n = 9) (B) patients with
CF (n = 12). (C) patients with CF after inhalation of hypertonic saline (n = 11). (D) Pediatric patients with CF. Data from [10].
doi:10.1371/journal.pone.0111972.g003
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Figure 4. DTPA absorption (mean+SEM) vs. model fit (line) for four patient subgroups. (A) Non-CF subjects (n = 9) (B) patients with CF
(n = 12). (C) patients with CF after inhalation of hypertonic saline (n = 11). (D) Pediatric patients with CF. Data from [10].
doi:10.1371/journal.pone.0111972.g004
Figure 5. Estimated Tc-SC retention trajectories for three patient subgroups. Non-CF (red with dashed line), CF IS (green with dotted
dashed line), CF HS (blue with line). Shaded envelope characterizes 95% confidence interval (CI) of retention prediction by the model. Pediatric CF
subjects not shown due to overlap with adult CF.
doi:10.1371/journal.pone.0111972.g005
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However, the parameter FFCA (Figure 7B), which describes the
fractional area of large airways with functional MCC, is
significantly lower in patients with CF versus non-CF subjects
(p,0.05). Patients with CF given HS, however, show a signifi-
cantly increased FFCA (p,0.05). This would support the concept
of increased MCC, not through an intrinsic rate increase, but
through an increase in the overall epithelial area contributing to
MCC.
Our model also agrees with the previous reports that
absorption, represented by kDB and kLB in our model, is increased
in patients with CF vs. non-CF subjects (p,0.001 both param-
eters). The model demonstrates that HS inhalation decreases
absorption in the peripheral lung (kDB), which includes both small
and intermediate sized airways and alveolar regions, more than IS
inhalation (p,0.001). All model parameters are similar when
comparing baseline measurements in the pediatric and adult CF
IS groups (p =NS). Our parameters, as well as those of similar
studies, are shown in Table 3.
In Vitro Evaluation of Model Prediction
In order to verify that hydration increases the fraction of
functional ciliated area, we imaged CF HBE cultures (6 lines,
n = 12) before and after addition of 10 mL of Dulbecco’s Modified
Eagle Media (DMEM) (Sigma-Aldrich, St. Louis, MO, USA), a
liquid cell culture media, to the apical surface and again after a
second addition of 10 mL of DMEM. We determined that
hydration of HBE cells by addition of 10 mL significantly increases
the fraction of functional ciliated area (p,0.0005) above baseline.
No further increase in FFCA was observed following a second
addition of 10 mL DMEM (p=NS), as shown in Figure 8A. CF
HBE cells were imaged following apical addition of either 5 mL IS
(n = 6) or HS (n= 6). A comparison of relative effect of IS and HS
in CF HBE cells is shown in Figure 8B. Both IS and HS additions
increase functional area (p,0.05 and p,0.001, respectively).
However, HS increases functional area significantly more than IS
(p,0.01).
Discussion
The failure of the CF airway epithelium to secrete Cl{ and
absorb Naz in a normal manner results in a net osmotic gradient
that favors rapid absorption of liquid from the ASL, resulting in
diminished MCC and an accumulation of dehydrated mucus in
the airways. Nuclear imaging methods have been previously
developed to measure MCC and have been used as biomarkers of
therapeutic efficacy. A novel method that measures both MCC
and ASL absorption has been explored more recently [10]. This
method involves the inhalation of radiolabeled particle and small
molecule probes (Tc-SC and DTPA, respectively). The difference
between total DTPA clearance and Tc-SC clearance can be used
to estimate the absorption of DTPA, and previous studies have
demonstrated: (i) a positive and significant correlation between
DTPA and ASL absorption rates [9]; (ii) DTPA absorption
response to the use of osmotic therapies both in vivo and in vitro
[10], [9].
We have developed a model that considers the basic mecha-
nisms governing small molecule and particle probe clearance from
physiologically distinct compartments of the lung. The combina-
tion of these mechanisms is reflected in the imaging result.
Compartment or mechanism specific results provide additional
insight into CF lung pathophysiology and therapeutic mechanisms
of action. They may also provide more sensitive and accurate
predictions of therapeutic efficacy than analyses of the composite
imaging data as the compartmental description incorporates the
inherent time-correlation of mass transport within the model
structure.
Figure 6. Estimated DTPA absorption trajectories for three groups. Non-CF (red with dashed line), CF IS (green with dotted dashed line), CF
HS (blue with line). Shaded envelope characterizes 95% confidence interval (CI) of retention prediction by the model. Pediatric CF subjects not shown
due to overlap with adult CF.
doi:10.1371/journal.pone.0111972.g006
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Model Structure Selection and Analysis
Our physically descriptive model includes central and periph-
eral lung compartments. The central zone includes large airways,
intermediate and small airways, and alveoli while the peripheral
zone includes only intermediate and small airways and alveoli
[18], [20] (See Figure S1). The peripheral zone includes both
smaller airways and alveoli in a single compartment. The model
also includes compartments for the trachea and blood. As
determined by Akaike Information Criterion (AIC) [21] analysis,
a quantitative metric that weights the model accuracy (as
measured by sum-squared error) against the cost of model
complexity (quantified by the number of parameters in a model),
the most appropriate model given the timeframe of our data
assumed zero MCC from the peripheral compartment. Model rate
constants describing MCC from the functional large airway
compartment (kLT ), absorption from the small airway/alveolar
compartment (kDB), large airway absorption (kLB), and FFCA
were fit to the data. The fixed mathematical structure of the model
is able to capture the dynamics of both MCC and the absorption
of DTPA in the lungs of all patient groups.
An alternative, and more highly parameterized, model than that
shown in Figure 2 would include parameter kDL as an MCC rate
constant from compartment D to compartment L, in addition to
MCC rate constant kLT and absorption rate constants kDB and
kLB. All kinetics were assumed to be first order. Furthermore, the
initial dosing of probes was included using a free dosing parameter
(C/P), representing the ratio of radiopharmaceutical doses
delivered to the large airways and peripheral lung. Under the
assumption that Technetium 99m-labeled Sulfur Colloid (Tc-SC)
is not absorbed in any lung region, the MCC curve was found to
be bi-exponential, as suggested previously [15]. However,
regression and analysis of the model parameters via the MATLAB
Figure 7. Least-squares solutions for model parameters are shown with 95% confidence intervals for four groups: Non-CF (NCF), CF
HS, CF IS, and Pediatric CF (CFP). (A) MCC rate constant (kLT ) (min
{1). (B) Fraction (FFCA) of large airway with functional MCC. (C) Peripheral lung
absorptive rate constant (kDB) (min
{1). (D) Large airway absorptive rate constant (kLB) (min
{1).
doi:10.1371/journal.pone.0111972.g007
Table 3. Pharmacokinetic Lung Clearance Parameter Values.
Study kLT (min
{1) kDB(min
{1)
NCF 0.0450+0.0085 0.0071+0.0005
CF HS 0.0393+0.0073 0.0105+0.0009
CF IS 0.0349+0.0076 0.0181+0.0012
CF Pediatric 0.0481+0.0173 0.0157+0.0014
Sakagami* [14] 0.022+0.002 0.048+0.003
Values from this study are shown with +95.
*PK model in isolated perfused rat lung. Three fluorescent markers used, but only the parameter values for sodium fluorescein (F-Na) are shown since
MWF{Na~376Da&MWDTPA .
doi:10.1371/journal.pone.0111972.t003
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functions lsqnonlin (a nonlinear least-squares regression algorithm)
and nlparci (an algorithm that computes confidence intervals on
estimated parameters from the covariance matrix) yielded wide
parameter confidence intervals, approximately +10 times the
nominal parameter value. By eliminating kDL the confidence
intervals on parameter estimates are tightened dramatically (the
worst case parameter CI from the model herein is kLB in non-CF
subjects which has CI’s that are +39% of the nominal value).
While a two-compartment model, like that proposed by
Sakagami in [15], may be used to describe clearance, the
parameters may not be able to be estimated with confidence if a
physiological rate process captured by a parameter in the model is
on the timescale of the experiment, or longer. The 80-minute
functional imaging session inherently limits the confidence that
can be derived for slower physiological processes. Therefore we
hypothesized that the departure from monoexponential clearance
seen in the retention curves could be explained by a non-zero
steady state value for pharmaceutical retention. While this is
aphysiologic over a period of days, an apparent non-zero baseline
would manifest if a slow clearance process was occurring and data
collection was short by comparison to the half-life of the clearance.
This behavior can be realized in a number of ways in a kinetic
model. In the present study, it is most easily incorporated by
adding a new compartment that has no apparent MCC
mechanism over the experimental timescale. Thus, while we
believe that MCC in D can be observed on a longer timescale, we
consider its mechanism to be practically unidentifiable (i.e. there is
insufficient data to inform this parameter) over the timescale
examined in the present work [22].
The model structure presented in Figure 2, and its grounding
assumptions discussed in the Results section may fail to include
mechanisms that could manifest on timescales longer than the
80 minute imaging period. To address the question of model
appropriateness on the timescales of our data, we compared our
model to the following alternative model structures with AIC as
the basis for quantitative comparison:
Case 1. Exclude kLB: DTPA absorption in L, represented by
rate constant kLB, is not appreciable over the 80-minute functional
imaging timescale and should not be regressed to achieve model fit
Case 2. Include kDL: MCC in D, represented by rate constant
kDL, is significant over the 80-minute functional imaging study
timescale
The AIC values of each case above, in comparison to the model
in Figure 2, are given in Table 4. These values demonstrate that
the Figure 2 model displays the best combination of model fit and
parsimony for the data set from [10]. Parsimony was especially
important for model selection between the nominal case and Case
2, where the difference between AIC of the two cases was less than
+1%. However, it is important to again note that there may in
fact be clearance mechanisms from D, LN , and LF that are not
accounted for in this model because of constraints on our ability to
quantitatively resolve their effects with confidence over the
timescale of imaging. This is illustrated graphically in Figure 9,
where it is clear that we cannot confidently identify the parameter
kDL employed in Case 2 above.
Parametric Considerations
In non-CF subjects, FFCA is found to be v1. To our
knowledge, the notion that not all of the surface of the conducting
airways has functional cilia is a novel finding in humans. Hoegger
et al. [23] recently report that even in the trachea, the most
conductive airway, of newborn pigs without CF&70% of particles
clear in ten minutes and that those same particles are only actively
moving &80% of the time. While this timeframe is considerably
shorter than the one in our study, it has been established that
particles can be retained in the conducting airways of non-CF
animals for a potentially significant amount of time. It would be
reasonable to assume that particles deposited deeper in the
Figure 8. FFCA determined in vitro in CF HBE cells is shown + SEM. (A) Activated area is significantly greater between 10 mL and baseline
(* pv0:0005) and 2610 mL and baseline (* pv0:0005). Activated area is not significantly greater between hydrated groups (pw0:05). (B) A two-tailed
t-test with unequal variances assumed reveals that the increase in active area induced by HS in cells is significantly greater than that of IS (* pv0:01).
doi:10.1371/journal.pone.0111972.g008
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airways, like those in our study, would be retained longer. Thus we
have further reason to believe, in addition to the in vitro findings
presented here, that our estimation of FFCA as a model parameter
is grounded in realistic physiology.
Our model asserts that the rate of DTPA absorption (kDB) is
increased in the peripheral lung (small airway and alveoli)
compartment of patients with CF as compared to non-CF
subjects. Hypertonic saline slows this rate to nearly non-CF levels.
Previous in vitro studies have related DTPA hyperabsorption to
liquid hyperabsorption [9]. It is assumed that DTPA hyperabsorp-
tion occurs via a paracellular mechanism, driven by increased
paracellular liquid absorption, as DTPA has no known transcel-
lular route by which to absorb. Therefore, it is likely that our
current result reflects the basic liquid absorption defect associated
with CF. The aerosol delivery techniques utilized to deliver the
radiopharmaceuticals targeted large and small airways through a
specialized breathing pattern. Additionally, transient correction of
the absorption defect would be expected after administration of an
inhaled osmotic therapy based on most current hypotheses of
airway disease in CF [24]. However, we cannot completely
exclude the possibility of alveolar effects that may be related to yet
undocumented physiological differences between the alveolar
regions of CF and non-CF lungs.
The rate at which DTPA absorbs in the large airways (kLB) is
similar to kDB in the CF IS, CF pediatric and non-CF groups.
However, while hypertonic saline decreases the value of kDB in
patients with CF, it has no significant effect on kLB. MCC is the
dominant clearance mode in the large airways in both IS and HS
cases. We have shown in vitro that HS modulates the FFCA of the
airway epithelium and have shown in vivo that increased MCC
can be attained by modulating FFCA without requiring change in
MCC rate. The two rate constants in the central region (kLT and
kLB) describe competing and correlated processes, whereas FFCA
describes a more macroscopic phenomenon. Therefore, we would
Figure 9. Least-squares solutions for model parameters in case 2 of Table 3 are shown for comparison to the selected model with
95% confidence intervals for four patient groups: Non-CF (NCF), CF HS, CF IS, and Pediatric CF (CP). (A) MCC rate constant (kLT) (min-1)
reiterates that kLT is the same in all groups. (B) Fraction (FFCA) of large airway with functional MCC. (C) Peripheral lung absorptive rate constant (kDB)
(min-1) and (D) large airway absorptive rate constant (kLB) are nearly identical to their analogs in the selected model. (E) MCC rate constant (kDL)
(min-1) from D to L is clearly unidentifiable, and the nominal value is much smaller than kLT in each group. Confidence intervals are also widened in
all parameters directly related to MCC.
doi:10.1371/journal.pone.0111972.g009
Table 4. AIC Values for Various Model Structures.
Model Case 1 Case 2
NCF 22546.28 22535.65 22543.38
CF HS 22430.25 22227.60 22426.25
CF IS 22775.62 22287.07 22775.57
CF Pediatric 21858.37 21597.47 21854.37
The Akaike Information Criterion (AIC) is a metric for determining the most appropriate model for a system, where better fit is balanced against a penalty for
overparameterization. Total AIC is shown as calculated from Equation 7 for all cases: 1) exclude kLB from model structure; 2) include kPL in model structure.
doi:10.1371/journal.pone.0111972.t004
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expect that a change in one rate constant in L would induce a
corresponding change in the other. Between IS and HS days there
is no change in kLT (the dominant process), so we would not
expect a change in kLB either. However, due to the increase in
FFCA, total MCC increases in the central lung after HS
inhalation, which results in less DTPA being present and able to
absorb in accordance with its unchanged rate constant. In effect,
the underlying rate of DTPA absorption is unchanged, but an
increase in total MCC as a result of increased FFCA leads to less
DTPA being available for absorption and a smaller total quantity
of DTPA absorbed in the CF HS case. In the case of D, however,
we have assumed there is no competing, certainly no governing,
MCC term in D. Thus, conditions affecting D must result changes
in kDB.
Study Limitations
A primary limitation of the functional imaging method utilized
is its inability to uniquely discern airways and alveoli. Given the
three dimensional nature of the lung architecture, small airways
and alveoli are likely to be included in any zone analyzed via 2D
imaging. The small sizes of these structures make them impossible
to differentiate from each other through direct imaging, though
other physiological measurements (such as 24 hr MCC) may help
to differentiate their functional effects. The limited time scale of
imaging (80 minutes) in the current study may have also limited
assessment of small airway mucociliary clearance. Extended-
duration imaging studies may yield additional data that can inform
processes with slower rates and model parameters such as kDL,
which was excluded from the Figure 2 model on AIC grounds.
Physiological Implications
Our original study (see [10]) described significant differences in
baseline whole lung DTPA absorption when comparing CF and
healthy subjects. MCC was decreased in the CF groups, but not at
statistically significant levels. In this study we find that MCC is
decreased (in a statistically significant way) in the CF IS group for
tw18 minutes. The difference between these two findings arises
from differences in the analysis tools used in this work versus the
endpoint analysis performed in [10]. The confidence intervals
presented here are around the parameters of the model, as
opposed to being derived from statistical analysis of a final
retention value, as in [10]. Our parameters govern the entire time-
course of clearance, and thus are informed by the entire dynamic
of the data given in [10]. The resulting confidence-interval-derived
envelopes in Figures 5 and 6 capture the uncertainty of each
physiologically descriptive parameter in the model. This is
achieved by simulating the model at all possible combinations of
upper and lower CIs for each parameter and determining the
extreme values of model prediction at every time point. Hence, the
CIs about our parameters are used to generate physiologically, as
opposed to empirically, informed predictions of clearance behav-
ior in each subject group population. The narrowness of our
parameter CIs indicates confidence in the model parameter
estimates (in that they are well informed from the dynamic data in
[10]) and generates narrow prediction envelopes in each case,
indicating a physiological difference in MCC dynamics between
patients with CF and non-CF subjects that is not found via our
previous endpoint-analysis methods.
Response to HS inhalation was apparent in terms of both
decreased absorption and increased MCC as compared to IS
inhalation. These trends are reflected in our modeled result. Our
model suggests that the observed increase in MCC following HS
inhalation is due to an increase in FFCA rather than an increase in
MCC rate, and a detailed analysis of this hypothesis using the in
vivo imaging data is ongoing. The model also predicts that FFCA
is reduced in patients with CF as compared to the healthy
population. We used this prediction as a hypothesis about inducing
a functional change in vivo that can be tested in vitro. To further
elucidate this phenomenon, and validate that such behavior is
possible, we performed in vitro studies with HBE cell cultures. A
quantitative visual assay of ciliary movement demonstrated that a
larger fraction of the cell culture surface was activated after the
addition of hypertonic saline vs. isotonic saline.
Clinical Relevance
Some previous imaging studies have shown significant differ-
ences in whole lung MCC between CF and non-CF subjects [25],
[26] while others have not [4]. By ascribing a fixed mathematical
structure to our model, we constrained the clearance curves to a
single family of dynamical forms, which allows for more sensitive
comparisons between the dynamical, and also endpoint, behavior
present from one patient group to another. This ultimately
increases our confidence in the model assertion that MCC is
decreased in patients with CF and can be increased by hypertonic
saline inhalation and, subsequently, that our model offers a better
tool than statistical models for use in clinically gauging MCC.
Applications of this model may include the design of dosing
regimens for agents targeting changes in MCC and/or absorption.
For example, the timeline of the effects associated with an osmotic
therapy (correction of liquid absorption defects) could be assessed
independently of the resulting secondary effects (recruitment of
functional ciliated airway, large and small airway clearance).
Dosing timed in accordance with the duration of the counter-
absorptive effect may provide more continuous clearance from the
lungs and patient benefit, though outcome assessment is beyond
the scope of the model at present. The model could also be used to
resolve the pharmacodynamics of medications with subtle,
complex, or multiple therapeutic effects, to the degree that these
agents impact MCC and absorption.
Conclusions
Our physiologically motivated compartmental model is able to
reproduce the clearance behavior of both large particle (Tc-SC)
and small molecule (DTPA) radiolabeled probes as informed by
functional imaging data. The model asserts that liquid absorption
rate is increased in the peripheral lung of patients with CF as
compared to non-CF subjects, and that hypertonic saline will
decrease the rate of absorption in patients with CF to near non-CF
levels. Our model also attributes increased MCC induced by
hypertonic saline treatment to an increase in airway surface area
with functional ciliary clearance, as opposed to an increased rate of
clearance. The physiology inherent to the model structure and
parameterization allow for increased sensitivity in gauging the
effects of hypertonic saline in vivo in a real-time manner. This
model should, therefore, be extendable to other treatments, both
present and future, that target the liquid hyperabsorption and
MCC deficiency present in cystic fibrosis.
Materials and Methods
Functional Imaging Methods
Data from previously reported clinical imaging studies were
utilized [10]. These studies included both adult (n = 12) and
pediatric (n = 9) patients with CF and healthy controls (n = 9). Raw
imagining data from this study can be found in Table S1. An
aerosol based functional imaging technique that measures the
clearance of two different radiopharmaceutical probes from the
lungs over 80 minutes was used. Indium-111-labeled diethylene
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triamine pentaacetic acid (DTPA) is a small molecule probe
(&500 Da) that is cleared from the lung through both absorption
and MCC while Technetium-99m-labeled sulfur colloid (Tc-SC) is
a particle probe (&300nm) that is cleared only by MCC. DTPA
absorption is calculated by subtracting the Tc-SC clearance rate
(MCC) from the total In-DTPA clearance rate. Both probes were
mixed and delivered together via nebulizer in the same liquid
aerosol. All patient studies were approved by the University of
Pittsburgh Institutional Review Board (clinicaltrial.gov numbers
NCT01223183 and NCT01486199).
The aerosolized probes were delivered simultaneously by
nebulizer using a technique that deposited aerosol primarily in
the airways [10]. Their clearance (normalized decrease in
radioactive counts over time) was then independently assessed
over 80 minutes using dynamic planar scintigraphy. Whole,
peripheral and central lung zones were considered, where the
central zone was defined as a rectangle with
1
2
the height and width
of the whole lung region of interest postioned along the medial
lung border and centered vertically. At t = 10 minutes (11th
imaging frame) subjects inhaled nebulized saline treatments for
10 minutes. Adult patients with CF inhaled 7% hypertonic saline
(HS, n= 11) on one testing day and isotonic saline (IS) on the
other. Control and pediatric CF subjects performed a single testing
day with isotonic saline. Previous in vitro studies have demon-
strated a relationship between DTPA and ASL absorption. Since
DTPA has no known route for intracellular transport this
relationship is presumably due to the contribution of paracellular
liquid flows. Changes in DTPA absorption in response to osmotic
therapies have previously been demonstrated both in vitro [9] and
in vivo [10]. Analysis of the Tc-SC and DTPA retention curves as
well as DTPA absorption plotted with a logarithmic ordinate
showed that the data did not follow a monoexponential profile,
which guided selection of the model structure and kinetics
necessary to accurately reproduce the data.
Initial Model Structure
Sakagami [15] proposed a robust modeling scaffold for inhaled
pharmaceuticals that takes into account the regional pharmaco-
kinetic differences between the large conducting airways (L) and
the distal lung (D), consisting of smaller airways and alveoli.
Analysis of the corresponding system of compartment-based
ordinary differential equations (ODEs) yielded a bi-exponential
retention curve for Tc-SC as proposed by Byron [14]. However,
this model structure could not be reconciled with the whole of the
data used herein (see Discussion).
Model Parameter Estimation
Regression of model parameters, regardless of model structure,
was performed sequentially as follows. Model parameters were
estimated using nonlinear least-squares regression (via lsqnonlin in
MATLAB, 2013, The MathWorks, Natick, MA) between model
predictions and experimental data. The experimental design
allowed for sequential estimation of the MCC and absorption rate
parameters as follows:
1. The parameters that govern MCC (kLT and FFCA) were fit to
the Tc-SC retention data.
2. The regressed MCC parameters were then fixed, and the
absorption rate parameters (kDB and kLB) were fit to the
absorption curve.
3. Parameter uncertainty was calculated using the nlparci
function in MATLAB (2013, The MathWorks, Natick,
MA) to obtain confidence intervals on all model parameters.
Model Analysis
The assumptions above were tested individually, and in
combination, for appropriateness using the Akaike Information
Criterion (AIC). Akaike [21] originally proposed that model
appropriateness could be assessed according to the equation:
AIC~({2)ln(maximum likelihood)z2k ð6Þ
Where a Gaussian distribution represents the maximum
likelihood of the data and k is the number of free parameters in
the model. Thus, the model with the least value of AIC is deemed
most appropriate in terms of model fit and parsimony. Yamaoka
and colleagues [27] further elaborated on this information
criterion by proposing that for a process with Gaussian error the
AIC can found from the equation:
AIC~Nln(
XN
i~1
((y^i){yi)
2=N)z2k ð7Þ
Where y^i is the model fit and yi is the data value at the i
th image
of our N=80n set because there are 80 images per patient and n
patients per study group.
In Vitro Assessment of Ciliary Activation
We developed an in vitro imaging assay to measure the fraction
of the epithelium that has functional MCC in order to test our
hypotheses that FFCA is decreased in CF and that hydration can
recruit areas of otherwise non-functional cilia. Fully differentiated
human bronchial epithelial (HBE) cell cultures were viewed using
a phase-contrast objective (Nikon Eclipse TI). These cultures were
derived from lungs removed at the time of lung transplantation
and prepared using previously described methods approved by the
University of Pittsburgh IRB [28]. A series of 10 images was taken
of each culture that allowed for the determination of the change in
pixel intensity between successive images in the stack. Ciliary beat
can be observed under these conditions and is characterized by a
change in light intensity measured by the camera. This change in
light intensity can be translated to a change in pixel intensity in the
images obtained when placed in sequence to form a movie of
ciliary motion (see Figure S2 and Video S1). The average change
in pixel intensity of all cultures was determined in both CF lines
(n = 6) and a non-CF line. Average changes in the intensity of each
pixel from 12 untreated cultures from the non-CF line were
measured and the average change in intensity over all pixels was
used as a baseline measurement of functional ciliary movement.
Pixels in each stack with average change in intensity greater than
the non-CF baseline were said to have functional ciliary
movement. To test the effect of osmotic agents, 5 mL of either
isotonic (300 mOsm) or hypertonic (600 mOsm) saline was added
to the apical surface of cells prior to imaging (see Table S2 for
data). To test for saturating effects of hydration, we sequentially
added Dulbecco’s Modified Eagle Medium (DMEM) from the
basolateral bath to the apical surface of the cultures as follows: 10
mL of DMEM was added to the apical surface of the cells from the
basolateral bath before the cells were imaged, and an additional 10
mL of basolateral DMEM was added to the apical surface prior to
a second, identical, imaging routine (see Table S3 for data).
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Supporting Information
Figure S1 Shown is the initial posterior frame of a Tc-
SC imaging series. The dotted outline of the right lung is a
tracing of the outline of the lung as it appears in a transmission
scan. The filled in blue rectangle is the C ROI. The remaining
lung ROI represents P.
(TIF)
Figure S2 A pseudo-color image of non-CF HBE cells
under 106 enhancement is shown. The viewing frame is
identical to that in Video S1. Darker (more blue) regions show
areas with lower average change in pixel intensity during Video S1
whereas lighter (more yellow) regions show areas with higher
average change. In combination with Video S1 we show that
regions that display little visible movement are more blue, and the
regions with visible motion, particularly the hurricane regions, are
more yellow.
(TIF)
Table S1 Raw Tc-SC and In-DTPA counts in whole lung
ROI and central lung ROI over the length of imaging.
(PDF)
Table S2 FFCA in CF HBE cells is shown at baseline
compared to a 5 ul addition of either isotonic or
hypotonic saline.
(PDF)
Table S3 FFCA in CF HBE cells is shown at baseline,
after one 10 ul addition of basolateral DMEM, and after
a second, sequential addition of basolateral DMEM.
(PDF)
Video S1 A video of ciliary motion in non-CF HBE cells
under 106 phase-contrast enhancement is shown. The
viewing frame is identical to that in Figure S2. Three hurricane
type regions of ciliary motion are visible in the field of view. In
combination with Figure S2 we show that regions that display little
visible movement have lower average change in pixel intensity,
and the regions with visible motion, particularly the hurricane
regions, have higher average change in pixel intensity.
(AVI)
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